The last day of the week and Spire Healthcare (LON:SPI), the private hospital operator, is a notable reporter on the corporate front. Broker Numis expects to see the momentum of the first quarter continue across the three payer groups - PMI, Sell-Pay and the NHS - when the company posts interims. It rates the shares an 'add'. Analyst Sally Taylor said she expects 10% revenue growth overall and expects NHS to be remain the strongest organic growth contributor. She forecasts underlying earnings (EBITDA) to be $87mln , which is a margin of 19% and an increase of 8.8% year-on-year. Notably the anlayst said: "We await details ofa third new hospital site as well as insight int Spire's longer term plans to gain a foothold in the lucrative London market. "Development of Spire's cancer centres continues to progress; we expect an update on trading at its Bristol facilility and a development progress update regarding its site in Essex, which is expected to complete in Q4, 2015." The NHS continues to face pressures, the broker notes. "..figures show that waiting lists increased for four months in a row to May 2015 and are now at the highest level seen since February 2008," it also highlighted.
Friday's agenda - healthcare in focus as Spire reports
The last day of the week and Spire Healthcare, the private hospital operator, is a notable reporter on the corporate front.